Integra LifeSciences (NASDAQ:IART) PT Raised to $28.00

Integra LifeSciences (NASDAQ:IART – Free Report) had its target price lifted by Citigroup from $24.00 to $28.00 in a research report report published on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the life sciences company’s stock. IART has been the topic of several other reports. StockNews.com cut Integra LifeSciences from a […]

Related Keywords

Switzerland , Swiss , Stuart Essig , Integra Lifesciences , Wells Fargo Company , Deerfield Management Companylp Series , Integra Lifesciences Holdings Corporation , Securities Exchange Commission , Morgan Stanley , Citigroup , Swiss National Bank , Free Report , Wells Fargo , Get Free Report , Chairman Stuart Essig , Exchange Commission , National Bank , Capital Management , Lifesciences Holdings Corporation , Codman Specialty Surgical , Integra Lifesciences Daily ,